Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
2024 · Alzheimer s Research & Therapy · 15 citations
https://doi.org/10.1186/s13195-024-01521-9
Brown University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
430
Citations
12
h-index
13
i10-index
Matthew D. Howe is an academic researcher from Brown University. The author has contributed to research in topics: Alzheimer's disease research and treatments & Intracerebral and Subarachnoid Hemorrhage Research & Dementia and Cognitive Impairment Research. The author has an h-index of 12, co-authored 40 publications.
ORCID: 0000-0002-6373-1535https://doi.org/10.1186/s13195-024-01521-9
https://doi.org/10.6084/m9.figshare.7231343
Click to start Chat